This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
MOUSE ANTI RETINOBLASTOMA GENE PROTEIN
catalog :
VMA00668
quantity :
100 µl
price :
346 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
reactivity :
human
application :
western blot
product information
EntityType :
PrecisionAb Monoclonal
EntityCategory :
Antibodies
ProductCode :
VMA00668
Description :
MOUSE ANTI RETINOBLASTOMA GENE PROTEIN
Specificity :
RETINOBLASTOMA GENE PROTEIN
TargetSpecies :
Human
Host :
Mouse
Format :
Purified
Isotypes :
IgG1
Applications :
WB
ApplicationTypes :
Western Blotting
Quantity :
100 µl
QuantityValue :
100
QuantityType :
ul
GOAccessions :
GO:0043550,GO:0045445,GO:0044419,GO:0043433,GO:0035189,GO:0031625,GO:0031575,GO:0050681,GO:0045749,GO:0051219,GO:0003713,GO:0003700,GO:0003677,GO:0007265,GO:0007050,GO:0006469,GO:0006338,GO:0019900,GO:0030521,GO:0030308,GO:0016605,GO:0016564,GO:0016514,GO:0008134,GO:0000785,GO:0000279,GO:0000084,GO:0000083,GO:0000080
GOTerms :
G1/S-specific transcription in mitotic cell cycle,regulation of transcription from RNA polymerase II promoter of G1/S-phase of mitotic cell cycle,regulation of transcription involved in G1/S-phase of mitotic cell cycle,S-phase of mitotic cell cycle,M-phase,chromosome scaffold,GO:0005717,microtubule/chromatin interaction,plasmid binding,GO:0000130,transcription co-activator activity,chromatin modeling,chromatin modelling,chromatin remodelling,down regulation of protein kinase activity,downregulation of protein kinase activity,down-regulation of protein kinase activity,inhibition of protein kinase activity,arrest of cell cycle progression,cessation of cell cycle,termination of cell cycle,Ras mediated signal transduction,TF binding,SWI-SNF complex,negative transcriptional regulator activity,transcriptional repressor activity,ND10,nuclear dot,PML NB,PML nuclear body,down regulation of cell growth,downregulation of cell growth,down-regulation of cell growth,inhibition of cell growth,androgen receptor signalling pathway,mitotic G1/S checkpoint,ubiquitin ligase binding,retinoblastoma-E2F complex,down regulation of transcription factor activity,downregulation of transcription factor activity,down-regulation of transcription factor activity,inhibition of transcription factor activity,interaction with another species,interspecies interaction,interspecies interaction with other organisms,myoblast cell differentiation,down regulation of S phase of mitotic cell cycle,downregulation of S phase of mitotic cell cycle,down-regulation of S phase of mitotic cell cycle,inhibition of S phase of mitotic cell cycle,negative regulation of S-phase of mitotic cell cycle,AR binding,phosphorylated protein binding
UniprotAccessions :
P06400
Gene :
RB1
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=5925
EntityFormats :
Purified
UNSPSC :
41116161
ProductForm :
Purified IgG - liquid
PriceGBP :
262
PriceEUR :
336
PriceUSD :
346 USD
PriceCHF :
366.24
PriceSEK :
3531
PriceNOK :
3599
PriceDKK :
2507
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.